Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $477.2500 (-3.79%) ($477.2500 - $477.2500) on Thu. Mar. 18, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.65% (three month average) | RSI | 64 | Latest Price | $477.2500(-3.79%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.3% a day on average for past five trading days. | Weekly Trend | REGN advances 3.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(52%) XLV(42%) DIA(36%) SPLV(36%) SPY(36%) | Factors Impacting REGN price | REGN will decline at least -0.825% in a week (0% probabilities). VIXM(-21%) UUP(-7%) VXX(-6%) TBT(-6%) IGOV(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.825% (StdDev 1.65%) | Hourly BBV | -1.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $482.28(-1.04%) | 10 Day Moving Average | $475.13(0.45%) | 20 Day Moving Average | $466.64(2.27%) | To recent high | -13.1% | To recent low | 6.9% | Market Cap | $50.602b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |